Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Frontiers in Aging Neuroscience
|
December 13, 2021
The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
Tara L Moore, Damon A Young, Ronald J Killiany, et al.
Experimental Neurology
|
December 3, 2014
Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties
Mario A Saporta, Vu Dang, Dmitri Volfson, et al.
Blood Advances
|
April 28, 2018
Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability
Georgette L Suidan, Pradeep K Singh, Sunita Patel-Hett, et al.
Bioelectronic Medicine
|
May 22, 2026
A novel, wearable, in-ear EEG technology to assess sleep and daytime sleepiness
Jonathan Berent, Prabhjyot Saini, Andrew X Stewart, et al.
Sleep
|
December 4, 2025
Classification and clustering on nocturnal polysomnography: distinctions and overlaps between central disorders of hypersomnolence
Marta Karas, Yishu Gong, Marco Vilela, et al.
NPJ Schizophrenia
|
November 21, 2020
Assessment of brain cholesterol metabolism biomarker 24S-hydroxycholesterol in schizophrenia
Joshua Chiappelli, Maria S Quinton, Dmitri Volfson, et al.
Clinical and Translational Science
|
August 1, 2019
Continuous Monitoring Using a Wearable Device Detects Activity-Induced Heart Rate Changes After Administration of Amphetamine
Elena S Izmailova, Ian L McLean, Greg Hather, et al.
Translational Psychiatry
|
May 25, 2019
Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder
Thomas A Lanz, Veronica Reinhart, Mark J Sheehan, et al.
Neuropharmacology
|
April 25, 2019
Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine
Christopher L Shaffer, Jason K Dutra, Wei Chou Tseng, et al.
Nature Communications
|
February 16, 2018
Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor
David L Gray, John A Allen, Scot Mente, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Frontiers in Aging Neuroscience
|
December 13, 2021
The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
Tara L Moore, Damon A Young, Ronald J Killiany, et al.
Experimental Neurology
|
December 3, 2014
Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties
Mario A Saporta, Vu Dang, Dmitri Volfson, et al.
Blood Advances
|
April 28, 2018
Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability
Georgette L Suidan, Pradeep K Singh, Sunita Patel-Hett, et al.
Bioelectronic Medicine
|
May 22, 2026
A novel, wearable, in-ear EEG technology to assess sleep and daytime sleepiness
Jonathan Berent, Prabhjyot Saini, Andrew X Stewart, et al.
Sleep
|
December 4, 2025
Classification and clustering on nocturnal polysomnography: distinctions and overlaps between central disorders of hypersomnolence
Marta Karas, Yishu Gong, Marco Vilela, et al.
NPJ Schizophrenia
|
November 21, 2020
Assessment of brain cholesterol metabolism biomarker 24S-hydroxycholesterol in schizophrenia
Joshua Chiappelli, Maria S Quinton, Dmitri Volfson, et al.
Clinical and Translational Science
|
August 1, 2019
Continuous Monitoring Using a Wearable Device Detects Activity-Induced Heart Rate Changes After Administration of Amphetamine
Elena S Izmailova, Ian L McLean, Greg Hather, et al.
Translational Psychiatry
|
May 25, 2019
Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder
Thomas A Lanz, Veronica Reinhart, Mark J Sheehan, et al.
Neuropharmacology
|
April 25, 2019
Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine
Christopher L Shaffer, Jason K Dutra, Wei Chou Tseng, et al.
Nature Communications
|
February 16, 2018
Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor
David L Gray, John A Allen, Scot Mente, et al.
Page
of 5